✦ LIBER ✦

P75 Neoadjuvant chemotherapy with paclitaxel (P) in breast cancer, T 3/4, N+ M0

✍ Scribed by H.G. Botto; M.E. Botto; M.L. Otegui-Araoz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P181 Factors influencing prognosis in no

✍ V.F. Semiglazov; R.M. Paltuev; I.V. Nikitina; V.V. Semiglazov; G.A. Dashyan; A.A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

P73 Neoadjuvant therapy in stage II with

✍ K. Enomoto; T. Ikeda; A. Matsui; M. Kitajima; J. Koh; S. Masamura; T. Kinoshita; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Local-Regional Recurrence With and Witho

✍ Himanshu Nagar; Elizabeth A. Mittendorf; Eric A. Strom; George H. Perkins; Julia 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Randomized trial comparing neo-adjuvant

✍ S.V.S. Deo; Manisha Bhutani; Nootan K. Shukla; Vinod Raina; Goura K. Rath; Joyde 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Neoadjuvant treatment with docetaxel, es

✍ T. Prayer-Galetti; P. Sperandio; M. Gardimann; V. De-Marco; E. Sacco 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 190 KB

360 - Optimal duration of neoadjuvant ch

✍ S. Charrier; J.P. Ferrière; F. Kwiatkowski; H. Curé; I. Van Praagh; V. Feillel; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 268 KB